Researchers have long known that glycosaminoglycan-binding proteins (HBPs) help control vital processes like cell growth, ...

Over the past year, drug discovery has gotten a massive boost from the CAS BioFinder Discovery Platform, which allows ...

Bringing a new drug to market can take about 10 years, but artificial intelligence may soon change that, said Phil Mounteney, ...

In the past, most targeted drug development efforts relied on single biomarkers, but cancer is far more complex. BostonGene’s ...

Juvenescence has acquired drug discovery company Ro5, a move that enhances its AI/machine learning capabilities and improves ...